Notice ID: 88d33786b3134105840ac538debe6393Combined Synopsis/Solicitation
AXION BIOSYSTEMS MAESTRO PRO MICROELECTRODE ARRAY (MEA) SYSTEM – BRAND NAME OR EQUAL
Archived on October 1, 2026. Combined Synopsis/Solicitation posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FOOD AND DRUG ADMINISTRATION) on September 9, 2026. Solicitation CBER-2026-135659.
NAICS 334516 (Analytical Laboratory Instrument Manufacturing). Set-aside: No Set aside used. Place of performance: Georgia. Original response deadline: . Full description on SAM.gov.
Description
This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with Federal Acquisition Regulation (FAR) Part 12, as implemented through the Revolutionary FAR Overhaul (RFO) model deviation and applicable Department of Health and Human Services (HHS) class deviations.
This announcement constitutes solicitation. Quotations are being requested, and a separate written solicitation will not be issued.
Solicitation No. CBER-2026-135659 is issued as a Request for Quotation (RFQ) for the purchase of an Axion BioSystems Maestro Pro Microelectrode Array (MEA) System, brand name or equal, together with the required software, consumables, installation, training, warranty, and an option for preventive maintenance.
This acquisition is not set aside for small business concerns and is being competed on an unrestricted basis.
The Government intends to issue a Firm-Fixed-Price purchase order using simplified procedures for commercial products and commercial services under RFO FAR Part 12.
Please refer to the Combined Synopsis-Solicitation Maestro Pro Microelectrode Array System Document and all the attachments for specfic details about the requirement
Overview
Agency:
Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Office:FOOD AND DRUG ADMINISTRATION
Posted:September 9, 2026
NAICS:334516: Analytical Laboratory Instrument Manufacturing
Last Updated:Oct 1, 2026
PSC:6640: LABORATORY EQUIPMENT AND SUPPLIES
Response Deadline:
Set-Aside:No Set aside used
Type:Combined Synopsis/Solicitation
Place of Performance:Georgia
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
Michele Jackson
Documents
Select documents to download
Showing 7 of 7 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Combined Synopsis/Solicitation | FOOD AND DRUG ADMINISTRATION | Sep 9, 2026 | 56.19 KB | |||
| Combined Synopsis/Solicitation | FOOD AND DRUG ADMINISTRATION | Sep 9, 2026 | 27.09 KB | |||
| Combined Synopsis/Solicitation | FOOD AND DRUG ADMINISTRATION | Sep 9, 2026 | 37.19 KB | |||
| Combined Synopsis/Solicitation | FOOD AND DRUG ADMINISTRATION | Sep 9, 2026 | 35.51 KB | |||
| Combined Synopsis/Solicitation | FOOD AND DRUG ADMINISTRATION | Sep 9, 2026 | 11.25 KB | |||
| Combined Synopsis/Solicitation | FOOD AND DRUG ADMINISTRATION | Sep 9, 2026 | 30.71 KB | |||
| Combined Synopsis/Solicitation | FOOD AND DRUG ADMINISTRATION | Sep 9, 2026 | 17.88 KB |
Lifecycle
Solicitation:
CBER-2026-135659- Combined Synopsis
- Combined SynopsisCurrentSep 9, 2026
AXION BIOSYSTEMS MAESTRO PRO MICROELECTRODE ARRAY (MEA) SYSTEM – BRAND NAME OR EQUAL
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Fisher Scientific. Acquisition Description: The NIH Clinical Center, Department of Transfusion Medicine (DTM), Infectious Diseases Section requires acquisition of a 1) Real-Time PCR System, 2) an Automated Nucleic Acid Extractor and 3) a microvolume spectrophotometer to support clinical research and the development, optimization, and validation of diagnostic assays for hepatitis viruses and other transfusion-transmitted pathogens. The required system must support generation of high-quality quantification data from clinical specimens, including viral RNA/DNA and host-derived nucleic acids. The instrument must enable applications such as targeted genome amplification, work with a wider dynamic detection range, support the library prep for viral genome sequencing, and assay development workflows necessary for evaluating test performance and refining diagnostic methods prior to implementation in a clinical testing environment. The system must meet the following functional and operational requirements: High data accuracy and reproducibility to ensure reliable detection of viral variants and evaluation of assay performance; Low- to moderate-throughput capability appropriate for assay development, pilot studies, and validation activities involving smaller sample sets; Rapid turnaround times to support iterative testing and optimization of clinical assays; Flexible run configurations that allow efficient processing of varying sample volumes without excess capacity; Cost-efficient operation, including the ability to minimize per-run and per-sample costs for pathogen detection; Integrated and streamlined workflows, including nucleic acid extraction, amplification, quantification and data analysis within a platform from the same vendor to reduce complexity and variability; Ease of use and standardized operation, supporting reproducibility and implementation in a clinical laboratory environment; Compatibility with established nucleic acid preparation and amplification methods and existing laboratory workflows. The flexibility to be using the systems in a CLIA certified environment. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000121) by 12:00 PM eastern standard time on 10/23/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | Special Notice | 334516 | No Set-Aside | 10/08/2026 | 10/23/2026 | Bethesda, MD | |
This is a combined synopsis/solicitation for commercial products prepared in accordance with RFO FAR part 12, using the combined synopsis/solicitation format at RFO FAR 12.202(b), as revised under the Revolutionary FAR Overhaul and the implementing HHS/IHS class deviation, and the simplified procedures for commercial products and commercial services at RFO FAR 12.201-1. This announcement constitutes the only solicitation; quotations are requested and a separate written solicitation will not be issued. Solicitation number IHS-SS-26-IHS1520507 is issued as a Request for Quotation (RFQ) for PCR Laboratory Analyzer. The associated NAICS code is 334516 — Analytical Laboratory Instrument Manufacturing (size standard 1,000 employees). | Combined Synopsis | 334516 | No Set-Aside | 09/24/2026 | 10/02/2026 | Clinton, OK | |
This is a solicitation for commercial products or commercial services prepared in accordance with the format in RFO 12.201-1, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued. This solicitation is being issued as a Request for Quote (RFQ) No. FA857127Q0006. | Solicitation | 334516 | No Set-Aside | 10/08/2026 | 10/26/2026 | Warner Robins, GA | |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: BD Biosciences. Acquisition Description: Flow cytometry is a critical technology used for immunophenotyping, cellular analysis, and functional assessment of immune cells in both clinical and research settings. Our laboratory’s BD FACSCanto™ II flow cytometer has been in service for an extended period and requires routine preventive maintenance and timely technical support to ensure reliable operation and minimize downtime. BD Biosciences is the manufacturer of the BD™ flow cytometry system and provides specialized maintenance services, technical expertise, and support specific to this system. The annual service agreement includes two preventive maintenance inspections and PM kits, one business day guaranteed response for emergency on-site service, unlimited service visits, software revisions released during the agreement period, and telephone support for instrument, reagents and application issues. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000233) by 12:00 PM eastern standard time on 10/23/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | Special Notice | 334516 | No Set-Aside | 10/13/2026 | 10/23/2026 | Bethesda, MD | |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Varian Medical Systems, Inc. Acquisition Description: The Clinical Center partners with the National Cancer Institute, Thoracic and Gastrointestinal Branch in offering diagnosis and treatment of cancer. The IntelliBlate Ximitry Probe is a specialized, single-use surgical instrument manufactured by Varian Medical Systems (a Siemens Healthineers company) designed for use with the IntelliBlate Microwave Ablation System. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000328) by 12:00 PM eastern standard time on 10/16/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | Special Notice | 334516 | No Set-Aside | 10/09/2026 | 10/16/2026 | Bethesda, MD |
Additional Details
Solicitation Number
CBER-2026-135659
Archive Date
Oct 1, 2026
Office Address
ROCKVILLE, MD, 20857